首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment
【24h】

In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment

机译:透明质酸杂交合作复合物的体外评价为潜在新眼科治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The purpose of this in vitro study was to assess the potential benefits of eye drops based on hybrid cooperative complexes (HCCs) obtained from high and low molecular weight hyaluronic acid (HA). Methods: Rheological measurements were performed to adjust the HCC concentration toward optimal resistance to drainage from the ocular surface. The viscosity and mucoadhesion profiles of the optimized preparation were derived. Primary porcine corneal epithelial cells were used for biological studies. Cells were exposed to dehydration after being pretreated with the HCC solution, and protection from desiccation was evaluated using cell viability assays. Time-lapse experiments were carried out to evaluate the ability of the HCC preparation to promote corneal wound healing. The characterization studies were performed in comparison with a control HA solution representative of commercial HA-based products. Results: The HCC formulation is able to deliver twice the amount of biopolymer compared with conventional products while avoiding discomfort due to excessive viscosity. The viscosity and mucoadhesion profiles allowed the authors to predict the longer in vivo retention and, therefore, an improved HCC formulation bioavailability. The new preparation also proved superior in protecting porcine corneal epithelial cells from desiccation and in hastening corneal cell wound repair in vitro.Conclusions: The results suggest that the developed formulation may be a promising topical ophthalmic medical treatment.
机译:目的:这种体外研究的目的是基于从高分子量透明质酸(HA)中获得的杂化协同络合物(HCC)来评估眼药水的潜在益处。方法:进行流变测量,以将HCC浓度调节到从眼表面的引流的最佳抗性。衍生优化制剂的粘度和粘膜粘附性。原发性猪角膜上皮细胞用于生物学研究。用HCC溶液预处理后暴露细胞在脱水,并使用细胞活力测定评估免受干燥的保护。进行时间流逝实验,以评估HCC制剂促进角膜伤口愈合的能力。与商业HA类产品的对照HA溶液进行比较进行表征研究。结果:与常规产品相比,HCC配方能够提供生物聚合物量的两倍,同时避免由于过度粘度而感到不适。粘度和粘膜粘附型材允许作者预测体内保留的更长,因此,改善了HCC配方生物利用度。新的制剂还在体外保护猪角膜上皮细胞和加速角膜细胞伤口修复方面的优异方法。结论:结果表明,发达的制剂可能是一个有前途的局部眼科医生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号